Treatment of Hodgkin's Lymphoma
The choice of treatment of HL is based on the stage at presentation and prognostic factors. Today, the most widely used approach is a combination of chemotherapy with radiation therapy. This approach yields a greater than 90% cure rate.
Early-stage (stage I-II) favourable disease is treated with short term chemotherapy with ABVD (Adriamycin, bleomycin, vinblastine, and dacarbazine) or BEACOPP or Stanford V regimen.
Radiation therapy (20-30 Gy) usually 2 to…
